Tenofovir is Superior to Entecavir in Patients with Treatment-naïve Hepatitis B e-Antigen–Positive Chronic Hepatitis B

BACKGROUND AND AIM: Chronic Hepatitis B (CHB) is a global health problem affecting around 400 million of people worldwide. Two available first-line antiviral drugs are tenofovir disoproxil fumarate (TDF) and Entecavir (ETV). Till date,there are few published reports from India comparing efficacy of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Exp Hepatol
Autores principales: Behera, Manas K., Pati, Girish K., Narayan, Jimmy, Mishra, Debakanta, Meher, Lalit K., Singh, Ayaskant, Uthansingh, Kanishka, Sahu, Manoj K.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7897859/
https://ncbi.nlm.nih.gov/pubmed/33679047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2020.05.003
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares